404 related articles for article (PubMed ID: 33012445)
1. Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma.
Simon TG; Chan AT
Clin Liver Dis; 2020 Nov; 24(4):549-576. PubMed ID: 33012445
[TBL] [Abstract][Full Text] [Related]
2. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.
Cunha V; Cotrim HP; Rocha R; Carvalho K; Lins-Kusterer L
Ann Hepatol; 2020; 19(3):232-237. PubMed ID: 31836424
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive strategies in hepatocellular carcinoma.
Singh S; Singh PP; Roberts LR; Sanchez W
Nat Rev Gastroenterol Hepatol; 2014 Jan; 11(1):45-54. PubMed ID: 23938452
[TBL] [Abstract][Full Text] [Related]
4. Statin and aspirin for prevention of hepatocellular carcinoma: what are the levels of evidence?
Carrat F
Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):9-11. PubMed ID: 24183917
[TBL] [Abstract][Full Text] [Related]
5. Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Goh MJ; Sinn DH
Clin Mol Hepatol; 2022 Jul; 28(3):380-395. PubMed ID: 35021597
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hepatocellular carcinoma in nonviral-related liver diseases.
Fan JG; Farrell GC;
J Gastroenterol Hepatol; 2009 May; 24(5):712-9. PubMed ID: 19646014
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
Noureddin M; Rinella ME
Clin Liver Dis; 2015 May; 19(2):361-79. PubMed ID: 25921668
[TBL] [Abstract][Full Text] [Related]
8. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
Tseng CH
Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
[TBL] [Abstract][Full Text] [Related]
10. Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma.
Sitia G; Iannacone M; Guidotti LG
J Hepatol; 2013 Nov; 59(5):1135-8. PubMed ID: 23742914
[TBL] [Abstract][Full Text] [Related]
11. Potential for statins in the chemoprevention and management of hepatocellular carcinoma.
Lonardo A; Loria P
J Gastroenterol Hepatol; 2012 Nov; 27(11):1654-64. PubMed ID: 22849701
[TBL] [Abstract][Full Text] [Related]
12. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
El-Serag HB; Johnson ML; Hachem C; Morgana RO
Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hepatocellular carcinoma: progress and challenges.
Shire AM; Roberts LR
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):49-64. PubMed ID: 22419004
[TBL] [Abstract][Full Text] [Related]
14. Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.
Della Corte C; Aghemo A; Colombo M
World J Gastroenterol; 2013 Mar; 19(9):1359-71. PubMed ID: 23538741
[TBL] [Abstract][Full Text] [Related]
15. Generic chemoprevention of hepatocellular carcinoma.
Athuluri-Divakar SK; Hoshida Y
Ann N Y Acad Sci; 2019 Mar; 1440(1):23-35. PubMed ID: 30221358
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis.
Shin S; Lee SH; Lee M; Kim JH; Lee W; Lee HW; Park MS; Park S; Kim TS; Choi DH
Medicine (Baltimore); 2020 Feb; 99(9):e19008. PubMed ID: 32118712
[TBL] [Abstract][Full Text] [Related]
17. Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials.
Kraglund F; Christensen DH; Eiset AH; Villadsen GE; West J; Jepsen P
Hepatol Commun; 2023 Jan; 7(1):e0013. PubMed ID: 36633465
[TBL] [Abstract][Full Text] [Related]
18. Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence.
Siegel AB; El-Serag HB
Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):493-5. PubMed ID: 23984995
[No Abstract] [Full Text] [Related]
19. Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
Nischalke HD; Klüners A; Nattermann J; Berg T; Strassburg CP; Lutz P
Hepatol Commun; 2021 Dec; 5(12):2151-2152. PubMed ID: 34558827
[No Abstract] [Full Text] [Related]
20. Molecular targets for prevention of hepatocellular carcinoma.
Blum HE
Dig Dis; 2002; 20(1):81-90. PubMed ID: 12145424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
